GeneDx Holdings Corp.
WGS
$56.33
$4.538.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.63% | 3.31% | |||
| Total Other Revenue | -74.21% | 15.00% | |||
| Total Revenue | -15.48% | 3.64% | |||
| Cost of Revenue | -7.28% | 13.97% | |||
| Gross Profit | -19.06% | -0.30% | |||
| SG&A Expenses | 2.80% | 6.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.02% | 11.52% | |||
| Operating Income | -104.08% | -294.65% | |||
| Income Before Tax | -242.40% | -146.75% | |||
| Income Tax Expenses | 259.04% | -328.34% | |||
| Earnings from Continuing Operations | -258.41% | -131.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -258.41% | -131.38% | |||
| EBIT | -104.08% | -294.65% | |||
| EBITDA | -182.89% | -312.50% | |||
| EPS Basic | -254.94% | -129.39% | |||
| Normalized Basic EPS | -52.91% | -222.62% | |||
| EPS Diluted | -254.94% | -129.39% | |||
| Normalized Diluted EPS | -52.91% | -222.62% | |||
| Average Basic Shares Outstanding | 0.98% | 0.88% | |||
| Average Diluted Shares Outstanding | 0.98% | 0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||